Watchlist Price Alert

ArriVent BioPharma Inc. C... (AVBP)

NASDAQ: AVBP · Real-Time Price · USD

23.60

0.13 (0.55%)

At close: Jun 06, 2025, 3:59 PM

22.41

-5.04%

After-hours: Jun 06, 2025, 05:03 PM EDT

ArriVent BioPharma Common Stock Balance Sheet Statement

Financials in USD. Fiscal year is undefined.

Fiscal Year	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q1 2022
Period Ending	Mar 31, 2025	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Mar 31, 2022
Cash & Equivalents	49.87M	74.29M	282.86M	298.67M	317.39M	150.39M	141.36M	157.83M	-163.37M	163.37M	n/a
Short-Term Investments	126.21M	144.57M	n/a	n/a	n/a	n/a	25M	25M	326.74M	n/a	n/a
Long-Term Investments	29.41M	47.68M	n/a	n/a	n/a	n/a	106K	n/a	n/a	n/a	n/a
Other Long-Term Assets	176K	126K	2.84M	125K	108K	2.84M	1.96M	82K	-163.37M	72K	-37.28M
Receivables	n/a	500K	761K	750K	875K	761K	1.09M	258K	n/a	500K	n/a
Inventory	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Current Assets	9.71M	7.44M	8.4M	8.35M	8.18M	8.69M	n/a	n/a	n/a	n/a	n/a
Total Current Assets	185.78M	226.98M	292.4M	308.51M	327.48M	159.97M	179.98M	198.69M	163.37M	182.62M	37.28M
Property-Plant & Equipment	120K	154K	187K	219K	250K	291K	44K	76K	n/a	139K	n/a
Goodwill & Intangibles	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Total Long-Term Assets	29.71M	47.96M	3.13M	344K	358K	3.13M	2.11M	158K	-163.37M	211K	-37.28M
Total Assets	215.5M	274.94M	292.71M	308.86M	327.84M	163.1M	182.09M	198.84M	n/a	182.83M	n/a
Account Payables	4.36M	3.78M	4.65M	3.81M	4.1M	4.53M	4.82M	6.46M	n/a	3.09M	n/a
Deferred Revenue	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Short-Term Debt	138K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Current Liabilities	8.45M	4.16M	7.2M	2.04M	n/a	n/a	n/a	n/a	n/a	2.46M	n/a
Total Current Liabilities	12.95M	17.27M	15.16M	12.1M	9.98M	11.62M	10.1M	12.81M	n/a	8.36M	n/a
Long-Term Debt	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Long-Term Liabilities	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	-41.22M
Total Long-Term Liabilities	n/a	14K	56K	98K	138K	177K	304.49M	n/a	n/a	11K	-41.22M
Total Liabilities	12.95M	17.29M	15.22M	12.2M	10.12M	11.8M	10.1M	12.81M	n/a	8.37M	-41.22M
Total Debt	138K	176K	213K	250K	285K	317K	44K	76K	n/a	139K	n/a
Common Stock	4K	3K	3K	3K	3K	n/a	4K	4K	n/a	4K	n/a
Retained Earnings	-302.72M	-238.33M	-217.7M	-197.14M	-175.26M	-157.84M	-136.65M	-122.25M	n/a	-88.51M	n/a
Comprehensive Income	-17K	-211K	n/a	0.00	n/a	n/a	-4K	-4K	-85.11M	-4K	-48.64M
Shareholders Equity	202.54M	257.65M	277.49M	296.66M	317.72M	151.3M	171.99M	186.03M	174.46M	174.46M	41.22M
Total Investments	155.63M	192.25M	n/a	n/a	n/a	n/a	25.11M	25M	326.74M	n/a	n/a